Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B3 and B9 for Stage I/II Periodontitis
NCT05435378Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Jul 2022
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 1, randomised, double-blind trial in periodontitis comparing Vitamin B3 Arm, Vitamin B9 Arm and Placebo Arm (3 arms). Primary endpoints: Myeloperoxidase at 90 days and Clinical Attachment Level at 90 days. Status: unknown.
02
Drugs
nicotinamidefolic acid
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05435378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05435378.